Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery System

PUBLISHER: Grand View Research | PRODUCT CODE: 1908597

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1908597

Intravenous Solutions Market Size, Share & Trends Analysis Report By Type, By Nutrients, By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Intravenous Solutions Market Summary

The global intravenous solutions market size was estimated at USD 13.8 billion in 2025 and is projected to reach USD 28.2 billion by 2033, growing at a CAGR of 9.57% from 2026 to 2033. This growth is attributed to the increasing prevalence of diseases, such as neurological diseases, gastrointestinal diseases, and cancer.

IV solutions provide essential nutrients and are a main source of energy. The rising rate of premature births in developed countries such as the U.S. and the UK are further fueling the demand for intravenous (IV) solutions, as these nations have advanced neonatal care infrastructure that relies heavily on IV therapy. In these countries, factors such as increasing maternal age, higher rates of assisted reproductive technologies (ART), and chronic maternal conditions such as diabetes and hypertension have contributed to a growing number of preterm deliveries. For instance, according to Tommy's, the premature birth rate in England and Wales rose to 7.9% in 2022, up from 7.5% in 2021, marking two consecutive years of increase. Over 53,000 babies were born prematurely in 2022.

Malnutrition is one of the major drivers of the IV solutions market. According to the WHO, in 2022, 2.5 billion adults were overweight, with 890 million living with obesity, while 390 million were underweight. Globally, 149 million children under 5 were stunted, 45 million were wasted, and 37 million were overweight or obese. This high prevalence of malnutrition globally contributes to market growth. According to UNICEF, poor nutrition in the first 1,000 days of an infant's life may lead to impaired cognitive ability and stunted growth. Starch, minerals, vitamins, amino acids, lipids, and other key substances must be present in an infant's diet. These essential nutrients can be administered through parenteral nutrition, which is expected to boost the market. A high number of malnourished children and premature neonates that require these nutrients is expected to further propel the market.

Global Intravenous Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global intravenous solutions market report based on type, nutrient, end use, and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition
  • Nutrients Outlook (Revenue, USD Million, 2021 - 2033)
  • Carbohydrates
  • Vitamins & Minerals
  • Single-dose Amino Acids
  • Parenteral Lipid Emulsion
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Home
  • Hospitals
  • Infusion Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-1-68038-137-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Nutrient
    • 1.2.3. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Number of Premature Births
      • 3.2.1.2. Increasing Incidence of Cancer
      • 3.2.1.3. Increasing Risk of Malnutrition
      • 3.2.1.4. Growing Geriatric Population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Shortage of Parenteral Nutrition Products
      • 3.2.2.2. Increased Use of Enteral Nutrition
      • 3.2.2.3. High Risk of Infections
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Regulatory Framework
      • 3.2.5.1. Standards and Compliances
        • 3.2.5.1.1. North America
        • 3.2.5.1.2. Europe
        • 3.2.5.1.3. Asia Pacific
        • 3.2.5.1.4. Latin America
        • 3.2.5.1.5. MEA
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Intravenous Solutions Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Type Market Share Movement Analysis, 2025 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (Revenue USD Million)
  • 4.4. Total Parenteral Nutrition
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 4.5. Peripheral Parenteral Nutrition
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)

Chapter 5. Intravenous Solutions Market: Nutrient Estimates & Trend Analysis

  • 5.1. Nutrient Segment Dashboard
  • 5.2. Nutrient Market Share Movement Analysis, 2025 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (Revenue USD Million)
  • 5.4. Carbohydrates
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 5.5. Vitamins & Minerals
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 5.6. Single-dose Amino Acids
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 5.7. Parenteral Lipid Emulsion
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 5.8. Others
    • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)

Chapter 6. Intravenous Solutions Market: End Use Estimates & Trend Analysis

  • 6.1. End use Segment Dashboard
  • 6.2. End use Market Share Movement Analysis, 2025 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (Revenue USD Million)
  • 6.4. Home
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 6.5. Hospitals
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 6.6. Infusion Centers
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)

Chapter 7. Intravenous Solutions Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market: Key Takeaways
  • 7.3. North America
    • 7.3.1. North America Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamic
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive insights
      • 7.3.2.4. U.S. Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamic
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive insights
      • 7.3.3.4. Canada Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamic
      • 7.3.4.2. Regulatory framework
      • 7.3.4.3. Competitive insights
      • 7.3.4.4. Mexico Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamic
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. Germany Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key country dynamic
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. UK Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamic
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. France Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamic
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive insights
      • 7.4.5.4. Italy Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamic
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive insights
      • 7.4.6.4. Spain Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key country dynamic
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive insights
      • 7.4.7.4. Denmark Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamic
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive insights
      • 7.4.8.4. Sweden Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamic
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Competitive insights
      • 7.4.9.4. Norway Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamic
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Japan Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamic
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. China Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamic
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. India Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamic
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. South Korea Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamic
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Australia Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamic
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Thailand Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Intravenous Solutions Market Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamic
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Brazil Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamic
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. Argentina Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamic
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. South Africa Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamic
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Saudi Arabia Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamic
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive insights
      • 7.7.4.4. UAE Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamic
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive insights
      • 7.7.5.4. Kuwait Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis/Company Market Share Analysis, (2025)
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Fresenius Kabi AG
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. B. Braun SE
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Baxter
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Otsuka Pharmaceutical Co., Ltd.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Pfizer, Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. JW Life Science
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Vifor Pharma
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. ICU Medical, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
Show more
Product Code: GVR-1-68038-137-5

List of Tables

  • Table 1. List of abbreviation
  • Table 2. List of secondary data sources
  • Table 3. North America Intravenous Solutions market, by country, 2021 - 2033 (Revenue USD Million)
  • Table 4. North America Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 5. North America Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 6. North America Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 7. U.S. Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 8. U.S. Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 9. U.S. Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 10. Canada Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 11. Canada Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 12. Canada Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 13. Mexico Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 14. Mexico Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 15. Mexico Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 16. Europe Intravenous Solutions market, by country, 2021 - 2033 (Revenue USD Million)
  • Table 17. Europe Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 18. Europe Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 19. Europe Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 20. Germany Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 21. Germany Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 22. Germany Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 23. Germany Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 24. UK Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 25. UK Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 26. UK Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 27. France Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 28. France Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 29. France Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 30. Italy Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 31. Italy Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 32. Italy Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 33. Spain Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 34. Spain Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 35. Spain Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 36. Sweden Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 37. Sweden Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 38. Sweden Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 39. Denmark Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 40. Denmark Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 41. Denmark Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 42. Norway Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 43. Norway Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 44. Norway Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 45. Asia Pacific Intravenous Solutions market, by country, 2021 - 2033 (Revenue USD Million)
  • Table 46. Asia Pacific Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 47. Asia Pacific Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 48. Asia Pacific Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 49. China Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 50. China Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 51. China Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 52. Japan Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 53. Japan Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 54. Japan Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 55. India Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 56. India Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 57. India Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 58. Australia Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 59. Australia Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 60. Australia Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 61. Thailand Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 62. Thailand Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 63. Thailand Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 64. South Korea Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 65. South Korea Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 66. South Korea Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 67. Latin America Intravenous Solutions market, by country, 2021 - 2033 (Revenue USD Million)
  • Table 68. Latin America Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 69. Latin America Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 70. Latin America Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 71. Brazil Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 72. Brazil Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 73. Brazil Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 74. Argentina Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 75. Argentina Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 76. Argentina Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 77. MEA Intravenous Solutions market, by country, 2021 - 2033 (Revenue USD Million)
  • Table 78. MEA Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 79. MEA Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 80. MEA Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 81. South Africa Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 82. South Africa Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 83. South Africa Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 84. Saudi Arabia Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 85. Saudi Arabia Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 86. Saudi Arabia Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 87. UAE Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 88. UAE Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 89. UAE Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 90. Kuwait Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 91. Kuwait Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 92. Kuwait Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)

List of Figures

  • Fig. 1 Intravenous solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape
  • Fig. 12 Intravenous solutions market dynamics
  • Fig. 13 Intravenous solutions market: PORTER's analysis
  • Fig. 14 Intravenous solutions market: PESTEL analysis
  • Fig. 15 Intravenous solutions market by type: key takeaways
  • Fig. 16 Intravenous solutions market, by typetype: market share, 2025 & 2033
  • Fig. 17 Total parenteral nutrition market, 2021 - 2033 (Revenue USD Million)
  • Fig. 18 Peripheral parenteral nutrition market, 2021 - 2033 (Revenue USD Million)
  • Fig. 19 Intravenous solutions market, by end-use: key takeaways
  • Fig. 20 Intravenous solutions market, by nutrients: market share, 2025 & 2033
  • Fig. 21 Carbohydrates market, 2021 - 2033 (Revenue USD Million)
  • Fig. 22 Single dose amino acid solution market, 2021 - 2033 (Revenue USD Million)
  • Fig. 23 Vitamins and minerals, 2021 - 2033 (Revenue USD Million)
  • Fig. 24 Parenteral lipid emulsion, 2021 - 2033 (Revenue USD Million)
  • Fig. 25 Others market, 2021 - 2033 (Revenue USD Million)
  • Fig. 26 Intravenous solutions market by end use: key takeaways
  • Fig. 27 Intravenous solutions market, by end use: market share, 2025 & 2033
  • Fig. 28 Home market, 2021 - 2033 (Revenue USD Million)
  • Fig. 29 Hospitals market, 2021 - 2033 (Revenue USD Million)
  • Fig. 30 Infusion Centers market, 2021 - 2033 (Revenue USD Million)
  • Fig. 31 Intravenous solutions market revenue, by region, 2025 & 2033 (Revenue USD Million)
  • Fig. 32 Regional marketplace: key takeaways
  • Fig. 33 Regional marketplace: key takeaways
  • Fig. 34 North America intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 US intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 39 Europe intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 France intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Italy intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Spain intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Sweden intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Norway intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 56 Asia Pacific intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 China intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 69 Latin America intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Mexico intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Brazil intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 76 MEA intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Africa intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Saudi Arabia intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 UAE intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Kuwait intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 85 Key company categorization
  • Fig. 86 Heat map analysis
  • Fig. 87 Company market share/position analysis, 2025
  • Fig. 88 Strategy mapping
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!